Medical Device Innovation Consortium Appoints 2016 Board of Directors; Michael Minogue Is Chairman

MDIC’s goal is to advance medical technology regulatory science for patient benefit

Minneapolis -- (BUSINESS WIRE) -- Medical Device Innovation Consortium (MDIC), a leader in advancing medical technology regulatory science for patient benefit today announced its 2016 Board of Directors and appointed Michael Minogue Chairman of the Board. MDIC is a public-private partnership between the medical technology industry, government and non-profit organizations to support faster, safer and more cost-effective development, assessment and review of important new medical technologies.

“Since the founding of MDIC, the Consortium has benefited from an engaged board of senior leaders that share our vision of protecting and promoting public health. We are pleased to have the momentum continue under Mike Minogue’s leadership as chairman. As a founding Board member, Mike helped shape our vision and recruit new members,” said Jeffrey Shuren, M.D., director, FDA’s Center for Devices and Radiological Health and founding MDIC Board of Directors executive committee member. “Technology continues to advance at an unprecedented rate. MDIC’s success in bringing the best minds throughout the ecosystem together in the pre-competitive space to address our most challenging regulatory science questions can help us realize our vision of U.S. patients having access to important new technologies first in the world.”

“It is a privilege to serve as Chairman of MDIC,” said Michael Minogue, Chairman and CEO of Abiomed and now MDIC Chairman. “Collaboration has always been a key to medical technology innovation. When MDIC was formed, our vision was to utilize collaborative communication and resources to accelerate innovation with regulatory science. I would like to acknowledge the leadership and vision of our founding chairman of the Board of Directors, Bill Hawkins. Under Bill’s tenure, MDIC has grown to over 50 members and delivered innovative tools supporting the science of patient preference and advanced computational modeling in clinical trials.”

“A critical aspect of developing an enduring organization is engaged leadership. Mike Minogue, and the rest of the MDIC Board will continue to build on the success we have achieved to date,” said William A. Hawkins III, founding chairman of the Board of Directors.

The Board approved the following roster of Directors at its February Board meeting.

• 2016 MDIC Board of Directors
• Peter Arduini, President, Chief Executive Officer and Director, Integra LifeSciences
• Mark Carlson, Vice President Global Clinical Affairs and Chief Medical Officer, St. Jude Medical
• Allan Coukell, Director of Drugs and Devices, The Pew Charitable Trusts
• Chip Hance, CEO, Creganna Medical
• William A Hawkins III, Lead Director, Immucor and Retired Chairman and CEO, Medtronic, Inc.
• Ross Jaffe, Managing Director, Versant Ventures and Director, National Venture Capital Association
• Tamara Syrek Jensen, Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services
• Kris Kandarpa, Director, Research Sciences and Strategic Directions, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
• Richard Kuntz, Senior Vice President and Chief Scientific, Clinical and Regulatory Officer, Medtronic, Inc.
• Bryan Luce, Retired Chief Science Officer, Patient-Centered Outcomes Research Institute (PCORI)
• Aran Maree, Chief Medical Officer, Medical Devices & Diagnostics, Johnson & Johnson
• Michael Minogue, President, CEO, and Chairman, Abiomed
• William Murray, President and CEO, Medical Device Innovation Consortium
• Richard Naples, Executive Vice President and Chief Regulatory Officer, BD
• Bryan Olin, Vice President, Clinical, Quality, and Regulatory, LivaNova
• Peter Saltonstall, President and CEO, National Organization for Rare Disorders (NORD)
• Randy Schiestl, Vice President, Global Technology, Boston Scientific Corporation
• Jeff Shuren, Director, FDA Center for Devices and Radiological Health
• Beth Staub, VP Global Regulatory Affairs and Quality Assurance, Stryker Corporation
• Dale Wahlstrom, Past President and CEO, Medical Alley Association and The Biobusiness Alliance of Minnesota
• Nadim Yared, President and CEO, CVRx

About Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. We work in the pre-competitive space to facilitate development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Our initiatives improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market.